Company page

Longeveron Inc.

Longeveron Inc. (ticker: LGVN) is a public company based in the United States, with a market capitalization of approximately $25.9 million. The company focuses on developing innovative therapies aimed at treating age-related and chronic conditions. Longeveron is dedicated to advancing its research and clinical programs to improve patient outcomes.